据辉瑞公司一位发言人说,除非疫苗在大规模临床试验中获得成功并能够成功生产,否则辉瑞公司和BioNTech公司将不会从美国政府获得任何资金。
Under the agreement, the government would also have an option to procure an additional 500 million doses. Pfizer said the price for the additional doses would be negotiated separately if the US orders them.
根据协议,美国政府还可以选择再采购5亿剂疫苗。辉瑞公司表示,如果美国再次订购,价格将另行协商。
The vaccine, if successful, will be made available to Americans at no cost, although their health insurance may be charged, the US department of Health and Human Services (HHS) said.
美国卫生与公众服务部表示,如果疫苗研制成功,美国人将免费接种,不过可能需要医疗保险付费。
Pfizer Chief Executive Albert Bourla has said the company intends to make a profit on the vaccine. He has also said that spending its own money, rather than government money to develop the vaccine should help speed the process.
辉瑞首席执行官阿尔伯特·布拉曾表示,公司打算从这种疫苗上获利。他还说,花公司的钱来研发疫苗应该比花政府的钱更有助于加快这一进程。
Pfizer hopes to start its pivotal late-stage trial of the vaccine as early as next week, pending regulatory approvals, Chief Scientific Officer Mikael Dolsten said in an interview.
【美国斥资近20亿美元签上亿剂疫苗合同】相关文章:
★ 健康补品西芹汁
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15